Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA

References

• Kakelar HM, Barzegari A, Dehghani J, et al. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer. 2019;22(1):23–36. doi: 10.1007/s10120-018-0867-1.
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6.
   PubMed Web of Science ®Google Scholar
• Jiang J, Chen Y, Shi J, et al. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017;36(2):199–212. doi: 10.1007/s10096-016-2810-x.
   PubMed Web of Science ®Google Scholar
• Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449–490. doi: 10.1128/CMR.00054-05.
   PubMed Web of Science ®Google Scholar
• Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxin. 2019;11(11):677. doi: 10.3390/toxins11110677.
   Google Scholar
• Santos MLC, de Brito BB, da Silva FAF, et al. Helicobacter pylori infection: beyond gastric manifestations. World J Gastroenterol. 2020;26(28):4076–4093. doi: 10.3748/wjg.v26.i28.4076.
   PubMed Web of Science ®Google Scholar
• Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: current status and future concepts. World J Gastroenterol. 2014;20(18):5283–5293. doi: 10.3748/wjg.v20.i18.5283.
   PubMed Web of Science ®Google Scholar
• Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008;5(6):321–331. doi: 10.1038/ncpgasthep1138.
   PubMedGoogle Scholar
• Talebi Bezmin Abadi A. Vaccine against Helicobacter pylori: inevitable approach. World J Gastroenterol. 2016;22(11):3150–3157. doi: 10.3748/wjg.v22.i11.3150.
   PubMed Web of Science ®Google Scholar
• Suerbaum S. Genetic variability within Helicobacter pylori. Int J Med Microbiol. 2000;290(2):175–181. doi: 10.1016/S1438-4221(00)80087-9.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang QL, Cheng DD, et al. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol. 2016;6:159. doi: 10.3389/fcimb.2016.00159.
   PubMed Web of Science ®Google Scholar
• Bonsor DA, Sundberg EJ. Roles of adhesion to epithelial cells in gastric colonization by Helicobacter pylori. Adv Exp Med Biol. 2019;1149:57–75.
   PubMed Web of Science ®Google Scholar
• Evans DG, Karjalainen TK, Evans DJ, Jr., et al. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol. 1993;175(3):674–683. doi: 10.1128/jb.175.3.674-683.1993.
   PubMed Web of Science ®Google Scholar
• Lundström AM, Blom K, Sundaeus V, et al. Hpaa shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains. Microb Pathog. 2001;31(5):243–253. doi: 10.1006/mpat.2001.0466.
   PubMed Web of Science ®Google Scholar
• Kavermann H, Burns BP, Angermuller K, et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med. 2003;197(7):813–822. doi: 10.1084/jem.20021531.
   PubMed Web of Science ®Google Scholar
• Carlsohn E, Nyström J, Bölin I, et al. Hpaa is essential for Helicobacter Pylori colonization in mice. Infect Immun. 2006;74(2):920–926. doi: 10.1128/IAI.74.2.920-926.2006.
   PubMed Web of Science ®Google Scholar
• Banga Ndzouboukou JL, Lei Q, Ullah N, et al. Helicobacter pylori adhesins: hpaa a potential antigen in experimental vaccines for H. pylori. Helicobacter. 2021;26(1):e12758. doi: 10.1111/hel.12758.
   PubMed Web of Science ®Google Scholar
• Xie W, Zhao W, Zou Z, et al. Oral multivalent epitope vaccine, based on ureb, hpaa, cat, and ltb, for prevention and treatment of Helicobacter pylori infection in C57bl/6 mice. Helicobacter. 2021;26(3):e12807. doi: 10.1111/hel.12807.
   PubMed Web of Science ®Google Scholar
• Fahimi F, Sarhaddi S, Fouladi M, et al. Phage Display-Derived antibody fragments against conserved regions of vaca toxin of Helicobacter pylori. Appl Microbiol Biotechnol. 2018;102(16):6899–6913. doi: 10.1007/s00253-018-9068-4.
   PubMed Web of Science ®Google Scholar
• Aiba Y, Umeda K, Rahman S, et al. Synergistic effect of anti-Helicobacter pylori urease immunoglobulin Y from egg yolk of immunized hens and Lactobacillus johnsonii no.1088 to inhibit the growth of Helicobacter pylori in vitro and in vivo. Vaccine. 2019;37(23):3106–3112. doi: 10.1016/j.vaccine.2019.04.045.
   PubMed Web of Science ®Google Scholar
• Fouladi M, Sarhadi S, Tohidkia M, et al. Selection of a fully human single domain antibody specific to Helicobacter pylori urease. Appl Microbiol Biotechnol. 2019;103(8):3407–3420. doi: 10.1007/s00253-019-09674-6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiao Y, Ji L, et al. Potential therapeutic effects of egg yolk antibody (igy) in Helicobacter pylori infections-a review. J Agric Food Chem. 2021;69(46):13691–13699. doi: 10.1021/acs.jafc.1c05398.
   PubMed Web of Science ®Google Scholar
• Juma SN, Gong X, Hu S, et al. Shark new antigen receptor (ignar): structure, characteristics and potential biomedical applications. Cells. 2021;10(5):1140. doi: 10.3390/cells10051140.
   PubMed Web of Science ®Google Scholar
• Camacho-Villegas T, Mata-Gonzalez T, Paniagua-Solis J, et al. Human tnf cytokine neutralization with a vnar from heterodontus francisci shark: a potential therapeutic use. MAbs. 2013;5(1):80–85. doi: 10.4161/mabs.22593.
   PubMed Web of Science ®Google Scholar
• Kandalaft H, Hussack G, Aubry A, et al. Targeting Surface-Layer proteins with Single-Domain antibodies: a potential therapeutic approach against Clostridium Difficile-Associated disease. Appl Microbiol Biotechnol. 2015;99(20):8549–8562. doi: 10.1007/s00253-015-6594-1.
   PubMed Web of Science ®Google Scholar
• Ebrahimizadeh W, Mousavi Gargari S, Rajabibazl M, et al. Isolation and characterization of protective anti-Lps nanobody against V. Cholerae O1 recognizing inaba and ogawa serotypes. Appl Microbiol Biotechnol. 2013;97(10):4457–4466. doi: 10.1007/s00253-012-4518-x.
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen M, Wang X, et al. Identification of anti-Tnfα vnar single domain antibodies from whitespotted bambooshark (Chiloscyllium plagiosum). Mar Drugs. 2022;20(5):307.
   Web of Science ®Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. Swiss-Model: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–w303. doi: 10.1093/nar/gky427.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with alphafold. Nature. 2021;596(7873):583–589. doi: 10.1038/s41586-021-03819-2.
   PubMed Web of Science ®Google Scholar
• Pierce BG, Wiehe K, Hwang H, et al. Zdock server: interactive docking prediction of Protein-Protein complexes and symmetric multimers. Bioinformatics. 2014;30(12):1771–1773. doi: 10.1093/bioinformatics/btu097.
   PubMed Web of Science ®Google Scholar
• Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372(3):774–797. doi: 10.1016/j.jmb.2007.05.022.
   PubMed Web of Science ®Google Scholar
• Matz H, Dooley H. Shark Ignar-Derived binding domains as potential diagnostic and therapeutic agents. Dev Comp Immunol. 2019;90:100–107. doi: 10.1016/j.dci.2018.09.007.
   PubMed Web of Science ®Google Scholar
• Cheong WS, Leow CY, Abdul Majeed AB, et al. Diagnostic and therapeutic potential of shark variable new antigen receptor (vnar) single domain antibody. Int J Biol Macromol. 2020;147:369–375. doi: 10.1016/j.ijbiomac.2020.01.039.
   PubMed Web of Science ®Google Scholar
• Fantini J, Garmy N, Yahi N. Prediction of Glycolipid-Binding domains from the amino acid sequence of lipid Raft-Associated proteins: application to hpaa, a protein involved in the adhesion of Helicobacter Pylori to gastrointestinal cells. Biochemistry. 2006;45(36):10957–10962. doi: 10.1021/bi060762s.
   PubMed Web of Science ®Google Scholar
• Hong KS, Ki MR, Ullah HMA, et al. Preventive effect of anti-Vaca egg yolk immunoglobulin (igy) on Helicobacter pylori-Infected mice. Vaccine. 2018;36(3):371–380. doi: 10.1016/j.vaccine.2017.11.082.
   PubMed Web of Science ®Google Scholar
• Shin JH, Yang M, Nam SW, et al. Use of egg Yolk-Derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter Pylori infection. Clin Diagn Lab Immunol. 2002;9(5):1061–1066. doi: 10.1128/cdli.9.5.1061-1066.2002.
   PubMedGoogle Scholar
• Kovacs-Nolan J, Mine Y. Microencapsulation for the gastric passage and controlled intestinal release of immunoglobulin Y. J Immunol Methods. 2005;296(1-2):199–209. doi: 10.1016/j.jim.2004.11.017.
   PubMed Web of Science ®Google Scholar
• Valdovino-Navarro BJ, Dueñas S, Flores-Acosta GI, et al. Neutralizing ability of a single domain vnar antibody: in vitro neutralization of Sars-Cov-2 variants of concern. Int J Mol Sci. 2022;23(20):12267.
   PubMed Web of Science ®Google Scholar
• O'Toole PW, Janzon L, Doig P, et al. The putative Neuraminyllactose-Binding hemagglutinin hpaa of Helicobacter pylori ccug 17874 is a lipoprotein. J Bacteriol. 1995;177(21):6049–6057. doi: 10.1128/jb.177.21.6049-6057.1995.
   PubMed Web of Science ®Google Scholar
• Lundstrom A, Bolin I, Bystrom M, et al. Recombinant hpaa purified from Escherichia Coli has biological properties similar to those of native Helicobacter pylori hpaa. APMIS. 2003;111(3):389–397. doi: 10.1034/j.1600-0463.2003.t01-1-1110203.x.
   PubMed Web of Science ®Google Scholar